Perspective Therapeutics appoints Joel Sendek as CFO, replacing Juan Graham

Perspective Therapeutics, Inc.

Effective Sept 4, 2025; Sendek brings over 30 years of biotech finance and equity research experience.
Sendek previously served as CFO at four biotech firms and raised over $2.5B in capital.
Compensation: $500k base salary, 40% target bonus, and 600,000 stock options vesting over 4 years.
No family relationships or material transactions with Sendek were reported.
Juan Graham will receive severance per his existing employment agreement upon signing a separation agreement.

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.